Integrated Diagnostics Holdings PLC Stock: Rating & Analysis 2026

5.8/ 10High
StockScorer score

Integrated Diagnostics Holdings PLC mainly meets criteria in the Profitability category. Result from 18 strategies checked.

View all strategies →
50%100%StockScorer score · Profitability: 66%StockScorer score · Growth: 44%StockScorer score · Valuation: 26%StockScorer score · Momentum: 16%StockScorer score · Quality: 26%StockScorer score · Balance sheet & risk: 50%ProfitabilityGrowthValuationMomentumQualityBalance sheet & riskStockScorer score
18Strategies checked

Match per strategy (excerpt)

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

  • Balanced GARPThe middle ground between value and growth: steady growth at a fair price.
    High
  • Piotroski F-Score (9-Point Check)Nine hard balance-sheet criteria: separating substance from downward spirals.
    High
  • Moat QualityCompanies with an economic moat: persistently high returns, defended margins.
    High
15 more strategies locked

Sign up for free to see the match across all strategies checked.

Unlock for free →

Metrics & fundamentals

P/E, ROE, margin, debt, cash flow and more for Integrated Diagnostics Holdings PLC, fully visible after signing up for free.

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

StockScorer score
IDHC.LIntegrated Diagnostics Holdings PLCthis page
LLYEli Lilly and CompanyHigh6.7
LLY.TOEli Lilly and CompanyMedium2.5
JNJJohnson & JohnsonHigh6.7
ABBVAbbVie Inclocked
UNHUnitedHealth Group Incorporatedlocked
Unlock the full peer comparison →

Integrated Diagnostics Holdings PLC stock at a glance

Integrated Diagnostics Holdings PLC stock (IDHC.L) is evaluated entirely rule-based in the StockScorer model. It currently reaches a StockScorer score of 5.8 out of 10, which corresponds to a high match with the underlying strategies. The classification is deliberately neutral and is not a recommendation to buy, hold or sell.

The rating focuses on profitability metrics such as margins, return on capital and earnings quality. Overall, the stock passes through 18 different strategies, from quality checks through growth and value approaches to dividend strategies.

Sector classification: Healthcare

Integrated Diagnostics Holdings PLC is assigned to the Healthcare sector. The sector classification makes it possible to compare the stock with peers from the same sector, for example in the peer comparison further up this page.

In healthcare, relevant criteria include earnings stability, research intensity and margin quality, among others. StockScorer compares many metrics against the sector average, so a stock is positioned not only in absolute terms but also relative to its sector.

How StockScorer rates Integrated Diagnostics Holdings PLC stock

StockScorer evaluates every stock entirely rule-based and without discretion. As a large-cap stock, Integrated Diagnostics Holdings PLC is additionally measured against the stricter liquidity and balance-sheet standards of established market leaders. The criteria met across the 18 strategies produce the match shown per strategy as well as the summarising StockScorer score.

This makes it possible to see at a glance which investment styles a stock fits, without doing the calculation yourself. The decision remains yours. The values shown are purely informational and not investment advice.

Frequently asked questions about Integrated Diagnostics Holdings PLC stock

How does Integrated Diagnostics Holdings PLC stock (IDHC.L) score in the StockScorer model?
Integrated Diagnostics Holdings PLC stock reaches a StockScorer score of 5.8 out of 10, which is a high match with the rule-based strategies. It fits the Profitability category best. All values are purely rule-based and updated every business day.
What does the StockScorer score mean?
The StockScorer score summarises on a scale of 0 to 10 how many of the checked rule-based criteria a stock meets. A higher value means a higher match with the underlying strategies. The score is a neutral metric and not a recommendation to buy or sell.
What sector is Integrated Diagnostics Holdings PLC in?
Integrated Diagnostics Holdings PLC is assigned to the Healthcare sector. StockScorer uses the sector classification, among other things, to relate the stock to comparable peers from the same sector.
Is Integrated Diagnostics Holdings PLC stock a buy?
StockScorer does not give buy, hold or sell recommendations. The page only shows how strongly the stock matches various rule-based strategies. Whether a stock fits your goals depends on your own assessment. This is not investment advice.
How up to date are the metrics?
Scores are recomputed every business day. Individual metrics such as P/E, ROE and margin, as well as the full peer comparison, are visible after a free sign-up, for licensing reasons.
Which stocks are comparable to Integrated Diagnostics Holdings PLC?
In the same Healthcare sector, StockScorer rates Eli Lilly and Company, Eli Lilly and Company, Johnson & Johnson, among others. The full peer comparison with scores and match per strategy is available after signing up.
Which strategies does Integrated Diagnostics Holdings PLC match?
Integrated Diagnostics Holdings PLC shows a match with GARP Ausgewogen, Piotroski F-Score (9-Punkte-Bilanzcheck), Burggraben-Qualität. The match across all strategies checked is visible after a free sign-up.

Unlock the full analysis for free

Signed up in 30 seconds. Free, cancel anytime.

  • All metrics: P/E, ROE, margin, debt, cash flow
  • Full peer comparison within the same sector
  • See the match across all strategies in detail
  • Apply your own scoring profile to any stock
  • Add the stock to your watchlist and track score changes
  • Daily updated ratings for 500+ stocks
Start for free →Already registered? Log in now

Not investment advice. The match shown reflects rule-based criteria and is not a recommendation to buy, hold or sell. Individual metrics are only visible after signing in, for licensing reasons.

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.